The Lynx Group

Maintenance Therapy

San Diego, CA—In patients with multiple myeloma (MM), the use of drug therapy as maintenance has been shown to prolong the length of time the disease is controlled. Specifically, use of maintenance therapy may affect overall survival, particularly when it is used after an autologous stem-cell transplant (ASCT).
Read Article


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: